113 related articles for article (PubMed ID: 342393)
1. Protection against syngeneic tumor grafts induced by inoculation with normal allogeneic tissues.
Bear RH; Roholt OA; Pressman D
Immunol Commun; 1977; 6(6):547-58. PubMed ID: 342393
[TBL] [Abstract][Full Text] [Related]
2. Syngeneic tumor rejection induced by immunization with normal allogeneic tissues.
Bear RH; Roholt OA; Pressman D
Immunol Commun; 1977; 6(3):217-25. PubMed ID: 885580
[TBL] [Abstract][Full Text] [Related]
3. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
Parmiani G; Invernizzi G
Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
[TBL] [Abstract][Full Text] [Related]
5. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
[TBL] [Abstract][Full Text] [Related]
6. Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays.
Kawashima K; Takeyama H; Takahashi T; Kato Y; Watanabe E; Suzuki H; Minam S; Isobe K; Yamada K; Ito Y
Gan; 1979 Dec; 70(6):769-76. PubMed ID: 94022
[TBL] [Abstract][Full Text] [Related]
7. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
8. Induction of tumor resistance in mice by L1210 leukemia cells persistently infected with HVJ (Sendai virus).
Takeyama H; Kawashima K; Yamada K; Ito Y
Gan; 1979 Aug; 70(4):493-501. PubMed ID: 229053
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of syngeneic tumor growth in rats immunized with allogeneic skin grafts.
Hosokawa M; Imamura M; Oikawa T; Nakayama M; Gotohda E; Sendo F; Kodama T; Kobayashi H
Int J Cancer; 1976 Sep; 18(3):369-74. PubMed ID: 783054
[TBL] [Abstract][Full Text] [Related]
10. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
[TBL] [Abstract][Full Text] [Related]
11. Effects of ethylene glycol monomethyl (EGME) and monoethyl (EGEE) ethers on the immunocompetence of allogeneic and syngeneic mice bearing L1210 mouse leukemia.
Houchens DP; Ovejera AA; Niemeier RW
Environ Health Perspect; 1984 Aug; 57():113-8. PubMed ID: 6499794
[TBL] [Abstract][Full Text] [Related]
12. Studies on immunological tolerance induced in mice by kidney allografts.
Inoue K; Niesen N; Albini B; Milgrom F
Int Arch Allergy Appl Immunol; 1991; 96(4):358-61. PubMed ID: 1809693
[TBL] [Abstract][Full Text] [Related]
13. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
14. Early growth of experimental tumors and the onset of concomitant immunity.
karakousis CP; Paolini NS; Sharma SD; Moore RH
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):211-7. PubMed ID: 6284514
[No Abstract] [Full Text] [Related]
15. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
16. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
[TBL] [Abstract][Full Text] [Related]
17. The use of allogeneic stimulation and exogenous interleukin for syngeneic tumor rejection.
Sherburne CG; Condie RM; Nnadi EC; Adlin M
Transplant Proc; 1987 Feb; 19(1 Pt 1):628-31. PubMed ID: 3493564
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of MuLV-gs expression in crosses between high and low leukemia incidence strains.
Hilgers J; Galesloot J
Int J Cancer; 1973 May; 11(3):780-93. PubMed ID: 4364724
[No Abstract] [Full Text] [Related]
19. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
Parmiani G; Ballinari D; Sensi ML
J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
[No Abstract] [Full Text] [Related]
20. Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia.
Bekesi JG; Roboz JP; Holland JF
Ann N Y Acad Sci; 1976; 277(00):313-31. PubMed ID: 1069551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
